Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Seladelpar treatment reduces IL-31 and pruritus in patients with primary biliary cholangitis
Andreas E. Kremer, Marlyn J. Mayo, Gideon M. Hirschfield, et al.
Hepatology (2023) Vol. 80, Iss. 1, pp. 27-37
Open Access | Times Cited: 14

Showing 14 citing articles:

Peroxisome proliferator–activated receptor delta and liver diseases
Tomoo Yamazaki, Edward E. Cable, Bernd Schnabl
Hepatology Communications (2025) Vol. 9, Iss. 2
Open Access
Pruritus in Chronic Cholestatic Liver Diseases, Especially in Primary Biliary Cholangitis: A Narrative Review
Tatsuo Kanda, Reina Sasaki, Naruhiro Kimura, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 5, pp. 1883-1883
Open Access
Seladelpar: First Approval
Sheridan M. Hoy
Drugs (2024)
Closed Access | Times Cited: 4
Potential Role of Bile Acids in the Pathogenesis and Treatment of PBC
Yi Lü, Danlin Wang, Liang Song
Journal of Contemporary Medical Practice (2025) Vol. 7, Iss. 2, pp. 99-102
Closed Access
Second‐Line Treatment for Patients With Primary Biliary Cholangitis: A Systematic Review With Network Meta‐Analysis
Edoardo G. Giannini, Andrea Pasta, Francesco Calabrese, et al.
Liver International (2024) Vol. 45, Iss. 1
Open Access | Times Cited: 3
The treatment of primary biliary cholangitis: from shadow to light
Sylvia Dražilová, Tomas Koky, Marian Macej, et al.
Therapeutic Advances in Gastroenterology (2024) Vol. 17
Open Access | Times Cited: 2
PPAR-Mediated Bile Acid Glucuronidation: Therapeutic Targets for the Treatment of Cholestatic Liver Diseases
Gina M. Gallucci, Colleen M. Hayes, James L. Boyer, et al.
Cells (2024) Vol. 13, Iss. 15, pp. 1296-1296
Open Access | Times Cited: 2
Evaluating the safety and efficacy of seladelpar for adults with primary biliary cholangitis
Allyce Caines, Sheri Trudeau, Stuart C. Gordon
Expert Opinion on Pharmacotherapy (2024) Vol. 25, Iss. 11, pp. 1517-1523
Closed Access | Times Cited: 2
PPARα, PPARδ, or both—that is the question!
Frank Wolters, Ronald P.J. Oude Elferink, Ulrich Beuers
Hepatology (2024) Vol. 80, Iss. 1, pp. 8-10
Open Access | Times Cited: 1
High C-reactive protein-to-albumin ratio levels are associated with osteoporosis in patients with primary biliary cholangitis
Yanyan Li, Bo Liu, Xin Li
Frontiers in Endocrinology (2024) Vol. 15
Open Access | Times Cited: 1
PPAR agonists in Primary Biliary Cholangitis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Hilária Saugo Faria, Milene Vitória Sampaio Sobral, Victor Gonçalves Soares, et al.
Research Square (Research Square) (2024)
Open Access
Pruritus, Fatigue, Osteoporosis and Dyslipoproteinemia in Pbc Patients: A Clinician’s Perspective
Sylvia Dražilová, Tomas Koky, Marian Macej, et al.
Gastroenterology Insights (2024) Vol. 15, Iss. 2, pp. 419-432
Open Access
Revisiting PPAR agonists: novel perspectives in the treatment of primary biliary cholangitis
Yiran Chen, Kunyu Zheng, G Morais M da, et al.
Expert Opinion on Pharmacotherapy (2024) Vol. 25, Iss. 13, pp. 1825-1834
Closed Access
PPAR agonists for the treatment of cholestatic liver diseases: Over a decade of clinical progress
Colleen M. Hayes, Gina M. Gallucci, James L. Boyer, et al.
Hepatology Communications (2024) Vol. 9, Iss. 1
Open Access
Page 1

Scroll to top